Table 5: Review of the grading and immunohistochemical profiles of the different published cases.
|
|
Grade |
ER |
HER2+ |
P 63 |
CK 5/6 |
CK 7 |
Ki-67 |
|
Hanna [13] |
NA |
+ |
NS |
NS |
NS |
NS |
NS |
|
Hanna [13] |
NA |
+ |
NS |
NS |
NS |
NS |
NS |
|
Hastrup[14] |
High |
- |
NS |
NS |
NS |
NS |
NS |
|
Markopoulos[4] |
High |
- |
NS |
NS |
NS |
NS |
NS |
|
Gomez Aracil [9] |
High |
+ |
NS |
NS |
NS |
+ |
positive |
|
Horii[3] |
Low |
+ |
1+ |
NS |
NS |
NS |
NS |
|
Hornychova[1] |
High |
- |
- |
20% |
+ |
weak |
25% |
|
Hornychova[1] |
Low |
- |
- |
15% |
+ |
+ |
40% |
|
Basbug [24] |
High |
- |
- |
NS |
NS |
NS |
NS |
|
Palermo[27] |
High |
- |
NS |
+ |
|
+ |
|
|
Fujino[2] |
Intermediate |
- |
- |
+ |
+ |
+ |
22% |
|
Turk[5] |
NS |
- |
NS |
NS |
NS |
+ |
NS |
|
Sherwell-Cabello[6, 28] |
Low |
- |
- |
+ |
+ |
+ |
5% |
|
Cheng[8] |
Low |
+ |
- |
- |
- |
- |
NS |
|
Cheng[8] |
Low |
- |
- |
- |
+ |
+ |
NS |
|
Cheng[8] |
Low |
10% |
- |
- |
- |
- |
NS |
|
Cheng[8] |
Low |
60% |
- |
+ |
+ |
+ |
NS |
|
Our |
Low |
+ |
NS |
+ |
+ |
+ |
5% |
ER: estrogen, HER2: human epidermal growth factor receptor 2, CK: cytokeratin, NA: not applicable, NS: not stated.